The 20 Best Mediastinal Tumor Doctors Near Me in Ann Arbor, MI

Benjamin Viglianti is a Radiologist and a Nuclear Medicine provider practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 17 years. Dr. Viglianti is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Neuroendocrine Tumor, Osteopenia, Melorheostosis with Osteopoikilosis, and Melorheostosis. Dr. Viglianti is board certified in Diagnostic Radiology and Nuclear Medicine.

Perry Pernicano is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Pernicano is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Chronic Cough, Synovial Sarcoma, Lung Nodules, and Cystic Fibrosis. Dr. Pernicano is board certified in Diagnostic Radiology.

Molly Roseland is a Radiologist practicing medicine in Ann Arbor, Michigan. She has been practicing medicine for over 10 years. Dr. Roseland is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Melorheostosis with Osteopoikilosis, Melorheostosis, and Osteopenia. Dr. Roseland is board certified in Diagnostic Radiology and Nuclear Medicine.

Tayson Lin is a Radiologist practicing medicine in Ann Arbor, Michigan. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. His clinical expertise encompasses Cystic Hygroma, Hygroma Cervical, Cavernous Lymphangioma, and Mediastinal Tumor.

Dr. Davenport is an internationally recognized expert on the safety and efficacy of radiographic contrast material. He has served on the U.S. Food and Drug Administration Medical Imaging Drugs Advisory Committee, the National Cancer Institute Clinical Imaging Steering Committee, and the American College of Radiology's Committee on Drugs on Contrast Media (current chair). He has numerous national responsibilities, is a co-author on national policy statements, has published over 150 manuscripts, was founder of the Michigan Radiology Quality Collaborative, and is a funded investigator. His primary clinical interests include patient safety, high-value care, and urologic imaging. Dr. Davenport is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Neuroendocrine Tumor, WT1-Related Wilms Tumor Syndromes, Prostatectomy, and Cardiac Ablation.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

David Odell is a General Surgeon and a Thoracic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Odell is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Lung Nodules, Non-Small Cell Lung Cancer (NSCLC), Endoscopy, and Gastrostomy.

Dr. Kalemkerian completed his medical education and training at Northwestern University and Johns Hopkins Oncology Center. From 1993-1999, he was a physician-scientist at Wayne State University/Karmanos Cancer Institute in Detroit. Since 1999, he has been on faculty in the Division of Hematology/Oncology at the University of Michigan, where he currently serves as the Associate Division Chief for Faculty Development and Education and the Associate Director of the Hem/Onc Fellowship Program. In addition to his work at UM, Dr. Kalemkerian has served on and led numerous grant review sections, editorial boards, and committees of national and international professional societies. He is a former chair of the NCCN Small Cell Lung Cancer Guideline Panel and the ASCO Scientific Program Committee’s Metastatic NSCLC and Professional Development and Education Tracks. Dr. Kalemkerian’s clinical interest is the care of people with lung cancer, thymic tumors, and mesothelioma, and his academic research interest is clinical and translational trials for thoracic cancers. His honors include the receipt of the American Society of Clinical Oncology’s (ASCO) Excellence in Teaching Award, the University of Michigan Outstanding Clinician Award, and Fellow of ASCO recognition. He has given over 230 invited lectures, authored more than 200 research articles, reviews, commentaries and book chapters, and edited two books on lung cancer. Dr. Kalemkerian is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Lung Adenocarcinoma. Dr. Kalemkerian is board certified in Internal Medicine and Medical Oncology.

Dr. Daniel Chang is a nationally and internationally recognized expert in radiotherapy for GI malignancies. His primary research interest is in advanced radiotherapy techniques, primarily with stereotactic body radiotherapy (SBRT). He has led several studies investigating and establishing the efficacy and safety for SBRT for these diseases for liver and pancreatic tumors. His other research interests include normal tissue tolerances, quality of life after radiotherapy, and combining radiotherapy with targeted agents. In addition, he has a strong interest in the use of radiotherapy, particularly in combination with systemic agents, in patients with metastatic disease. Another area of interest is in health care utilization for patients with metastatic disease and using machine learning and other approaches to optimize care during the end-of-life period.Dr. Chang is interested in developing novel modalities and technologies for delivering radiotherapy. He previously led the FDA trial that led to approval of PET-guided radiotherapy, which in broader terms, is called Biology-guided radiotherapy. In addition, he has experience with MR-guided radiotherapy, and he is interested in exploring the role of particle therapy and heave ion radiotherapy.Dr. Chang received his MD from Wayne State University in 2002 and completed his residency in Radiation Oncology at the University of Florida in Gainesville, Florida in 2007. He then joined the Department of Radiation Oncology at Stanford University from 2007-2022, having previously served as residency program director from 2012-2017 and the Vice Chair of Clinical Operations from 2017-2022 where he was also the Sue and Bob McCollum Professor in Radiation Oncology.Dr. Chang is a member of the American Society of Radiation Oncology (ASTRO), American Radium Society (ARS), and the American Society of Clinical Oncology (ASCO). He serves on the scientific committee for ASTRO, ASCO, and GI ASCO. He has authored or co-authored over 190 peer-reviewed publications for journals including Journal of Clinical Oncology, Journal of the National Cancer Institute, Clinical Cancer Research, Radiology, International Journal of Radiation Oncology, Biology, and Physics, Radiotherapy and Oncology, and Cancer. He served as the senior editor for the GI section of the International Journal of Radiation Oncology, Biology, and Physics from 2013-2017 and is currently on the editorial board for Practical Radiation Oncologysince 2020. He served on the Hepatobiliary Panel for the National Cancer Comprehensive Network (NCCN) guidelines from 2013-2022, helping to shape national guidelines for the work-up, diagnosis, and treatment of patients with hepatobiliary cancers. He is currently the track chair for the GI track for the ASTRO Annual Meeting Scientific Committee. He also serves on the Education Committee for the Gastrointestinal Cancer - Gastroesophageal, Pancreatic, and Hepatobiliary Track for the ASCO annual meeting starting in 2023. Dr. Chang is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Familial Pancreatic Cancer. Dr. Chang is board certified in Radiation Oncology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Zachery Reichert is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Reichert is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.

Dr. David Smith is a Professor of Internal Medicine and Urology at the University of Michigan and currently serves as the Associate Chief Clinical Officer for Cancer at Michigan Medicine and the Chief Medical Officer of the Rogel Cancer Center. Throughout his career he has focused on caring for patients with urologic cancers, cancer clinical trials, and the delivery of cancer care. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Orchiectomy, and Prostatectomy.

Joseph Gemmete is a Neuroradiologist practicing medicine in Ann Arbor, Michigan. Dr. Gemmete is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Arteriovenous Malformation, Chylous Ascites, Retroperitoneal Fibrosis, Stent Placement, and Thrombectomy.

Lily Sung is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Sung is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Glycogen Storage Disease Type 6, Splenic Infarction, Mediastinal Tumor, and Babesiosis.

Dr. Jackson is an Assistant Professor in the Department of Radiation Oncology at the University of Michigan. He performed his residency in radiation oncology at the University of Michigan, and subsequently joined the faculty upon completion of his training. Within the Department of Radiation Oncology, he serves as the co-Chief of the Genitourinary Radiotherapy Program. Within the Rogel Cancer he is the co-Director of the multidisciplinary Spine Oncology Program.Dr. Jackson’s research focuses mainly on improving outcomes for men with aggressive or recurrent prostate cancer, and he has published extensively on this topic. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Penile Cancer. Dr. Jackson is board certified in Radiation Oncology.

Ronald Maggiore is a Geriatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Maggiore is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Squamous Cell Lung Carcinoma.

Tareq Baghdadi is a Hematologist practicing medicine in Ypsilanti, Michigan. Dr. Baghdadi is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 40 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Colorectal Cancer, Pleuropulmonary Blastoma, Tissue Biopsy, and Bone Marrow Aspiration.

Robert Lyons is a General Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Lyons is rated as an Experienced provider by MediFind in the treatment of Mediastinal Tumor. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Aortic Valve Stenosis, Thoracic Aortic Aneurysm, Aortic Regurgitation, Heart Bypass Surgery, and Transcatheter Aortic Valve Replacement (TAVR).